Advertisement

“Pill in the Pocket”: How Effective and Safe is this Strategy for Treatment of Recurrences of Atrial Fibrillation?

  • A. Capucci
  • G. Q. Villani
  • G. Rusticali
  • M. F. Piepoli
Conference paper

Abstract

Atrial fibrillation (AF) is a very common type of arrhythmia, which is considered to be the most frequent arrhythmia leading to hospital admission [1]. Several substrates underlie this arrhythmia, and different mechanisms are involved in its onset: it is a clinical challenge because there are several diagnostic and therapeutic options, making it a money- and time-consuming entity.

Keywords

Atrial Fibrillation Sinus Rhythm Atrial Flutter Paroxysmal Atrial Fibrillation Restore Sinus Rhythm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Furberg CD, Bruco MP, Manclio TA et al, for the CHS Collaborative Research Group (1994) Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 74:236–241PubMedCrossRefGoogle Scholar
  2. 2.
    Borgeat A, Goy JJ, Maendly R et al (1986) Flecainide versus quinidine for conversion of AF to sinus rhythm. Am J Cardiol 58:496–501PubMedCrossRefGoogle Scholar
  3. 3.
    Negrini M, Gibelli G, De Ponti C (1990) Confronta fra amiodarone e chinidina nella conversione a ritmo sinusale della fibrillazione atriale di rcente insorgenza. G Ital Cardiol 20:207–213PubMedGoogle Scholar
  4. 4.
    Roden DM, Woosley RL, Primm RK (1986) Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J 111:1088–1093PubMedCrossRefGoogle Scholar
  5. 5.
    Donovan KD, Dobb GJ, Cooms LJ et al (1992) Efficacy of flecainide for the reversion of acute onset AF. Am J Cardiol 70:50A–55APubMedCrossRefGoogle Scholar
  6. 6.
    Kingma JH, Suttorp MJ (1992) Acute pharmacologie conversion of AF and flutter: the role of flecainide, propafenone and verapamil. Am J Cardiol 70:56A–61APubMedCrossRefGoogle Scholar
  7. 7.
    Madrid AH, Moro C, Marin-Huerta E (1993) Comparison of flecainide and procami-de in cardioversion of AF. Eur Heart J 14:1127–1131PubMedCrossRefGoogle Scholar
  8. 8.
    Barranco F, Sanchez M, Rodriguez J et al (1994) Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficency. Int Care Med 20:42–44CrossRefGoogle Scholar
  9. 9.
    Donovan HD, Power BM, Hockings BE et al (1995) Intravenous flecainide versus amiodarone for recent onset AF. Am J Cardiol 75:693–697PubMedCrossRefGoogle Scholar
  10. 10.
    Villani GQ, Rosi A, Piepoli M et al (1990) Efficacia del trattamento orale con flecainide nella fibrillazione atriale parossistica: correlazione con 1e concentrazioni plasma-tiche. G Ital Cardiol 20:564–568PubMedGoogle Scholar
  11. 11.
    Capucci A, Lenzi T, Boriani G et al (1992) Effectiveness of loading oral flecainide for converting recent onset AF to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 70:69–72PubMedCrossRefGoogle Scholar
  12. 12.
    Botto GL, Bonini W, Broffoni G et al (1994) Regular ventricular rhythms before conversion of recent onset AF to sinus rhythm. Pacing Clin Electrophysiol 17:2114–2117PubMedCrossRefGoogle Scholar
  13. 13.
    Sihm J, Hansen FA, Rasmussen J et al (1990) Flecainide acetate in atrial flutter and fibrillation. The arrhythmogenic effects. Eur Heart J11:145–148Google Scholar
  14. 14.
    Ahsan A, Aldridge R, Bowes R (1993) 1:1 Atrioventricular conduction in atrial flutter with digoxin and flecainide. Int J Cardiol 39:88–90Google Scholar
  15. 15.
    Helmy I, Scheinman NM, Herre JM et al (1990) Electrophysiologic effects of isoprote-renol in patients with reentrant atrioventricular tachycardia treated with flecainide. J Am Coll Cardiol 16:1649–1655PubMedCrossRefGoogle Scholar
  16. 16.
    Suttorp MJ, Kingma HJ, Jessurun ER et al (1990) The value of class 1C antiarrhythmic drugs for acute conversion of paroxysmal AF or flutter to sinus rhythm. J Am Coll Cardiol 16:1722–1730PubMedCrossRefGoogle Scholar
  17. 17.
    Capucci A, Boriani G, Rubino I et al (1994) A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset AF to sinus rhythm. Int J Cardiol 43:305–313PubMedCrossRefGoogle Scholar
  18. 18.
    Capucci A, Boriani G, Botto GL et al (1994) Conversion of recent-onset AF by a single oral loading dose of propafenone and flecainide. Am J Cardiol 74:503–505PubMedCrossRefGoogle Scholar
  19. 19.
    Capucci A, Villani GQ, on behalf of SATE Investigators (1995) Propafenone oral loading dose plus digitalis in converting AF to sinus rhythm: a placebo-controlled multi-center study (abstract). Eur Heart J 92:1–775Google Scholar
  20. 20.
    Hohnloser SH, van de Loo A, Baedeker F (1995) Efficacy and proarrhythmic hazards of pharmacologic cardioversion of AF: prospective comparison of sotalol versus quinidine. J Am Coll Cardiol 995:852–858CrossRefGoogle Scholar
  21. 21.
    Alboni P, Tomasi C, Menozzi C et al (2001) Efficacy and safety of out-of-hospital self-administered single oral drug treatment in the management of infrequent well-tolerated paroxysmal supraventricular tachycadia. J Am Coll Cardiol 37:548–553PubMedCrossRefGoogle Scholar
  22. 22.
    Villani GQ, Marrazzo N, Rosi A et al (2001) Loading oral propafenone in paroxysmal AF: reproducibility and speed of effect (abstract). Eur Heart J 22 [Suppl]:327Google Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • A. Capucci
    • 1
  • G. Q. Villani
    • 1
  • G. Rusticali
    • 1
  • M. F. Piepoli
    • 1
  1. 1.Cardiology Department“Guglielmo da Saliceto” General HospitalPiacenzaItaly

Personalised recommendations